Mounjaro, Zepbound shortage eases as supplies of weight loss drug rebound The popular weight-loss and diabetes medication tirzepatide is no longer in short supply, the Food and Drug Administration said
The patient story is a fictionalized educational example inspired by themes commonly discussed during medical weight-loss consultations
Patients should be instructed to check the medication before each use for any signs of degradation or contamination
Arjunan A, Sah DK, Woo M, Song J (2023) Identification of the molecular mechanism of insulin-like growth factor-1 (IGF-1): a promising therapeutic target for neurodegenerative diseases associated with metabolic syndrome
( JAMA Network Open , 2022) If youre considering taking Ozempic or semaglutide, be sure to contact your healthcare provider, who can determine whether the drug is right for you